AML	Acute Myeloid Leukemia
allo-HSCT	allogeneic Hematopoietic Stem Cell Transplantation
APL	Acute Promyelocytic Leukemia
Aza	Azacitidine
BM	Bone Marrow
BCOR	BCL6 Corepressor
BRD4	Bromodomain-Containing Protein 4
BRG1	Brahma-Related Gene 1
BRM	Brahma
CAR-T	Chimeric Antigen Receptor T-Cell
CR	Complete Remission
CRc	Composite Complete Remission
CRh	Complete Remission with partial hematologic recovery
dPCR	digital Polymerase Chain Reaction
EFS	Event-Free Survival
ELN	European LeukemiaNet
EOT	End Of Treatment
FLT3	FMS-Like Tyrosine Kinase 3
FLT3-ITD	FLT3 Internal Tandem Duplication
FLT3i	FLT3 inhibitor
GO	Gemtuzumab Ozogamicin
ICC	International Consensus Classification
IHC	Immunohistochemistry
KMT2A	Lysine Methyltransferase 2A
MFC	Multiparameter Flow Cytometry
MR	Myelodysplasia-related
MRD	Measurable Residual Disease
MYC	MYC Proto-Oncogene
NES	Nuclear Export Signal
NGS	Next-Generation Sequencing
NoLS	Nucleolar Localization Signal
NPM1	Nucleophosmin 1
ORR	Overall Response Rate
OS	Overall Survival
PB	Peripheral Blood
PCR	Polymerase Chain Reaction
PCGF1	Polycomb Group Ring Finger Protein 1
PRC1.1	Polycomb Repressive Complex 1.1
qPCR	quantitative Polymerase Chain Reaction
R/R	Relapsed/Refractory
SMARCA2/4	SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily A, Member 2/4
SWI/SNF	SWItch/Sucrose Non-Fermentable chromatin-remodeling complex
UHS-NGS	Ultrahigh-Sensitivity Next-Generation Sequencing
Ven	Venetoclax
XPO1	Exportin 1